Hak N. Kim
Cheongju-si, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
N-Degron-Based PROTAC Targeting PLK1: A Potential Therapeutic Strategy for Cervical Cancer.
Journal: Pharmaceutics
Published: July 07, 2025
Degradation of Polo-like Kinase 1 by the Novel Poly-Arginine N-Degron Pathway PROTAC Regulates Tumor Growth in Nonsmall Cell Lung Cancer.
Journal: Journal of medicinal chemistry
Published: December 18, 2023
Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Journal: Protein expression and purification
Published: February 15, 2022
An Activatable T1-Weighted MR Contrast Agent: A Noninvasive Tool for Tracking the Vicinal Thiol Motif of Thioredoxin in Live Cells.
Journal: Molecules (Basel, Switzerland)
Published: March 02, 2021
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models.
Journal: Journal of medicinal chemistry
Published: November 03, 2020
Vitamin E-Conjugated Phosphopeptide Inhibitor of the Polo-Box Domain of Polo-Like Kinase 1.
Journal: Molecular pharmaceutics
Published: October 31, 2019
Amphiphilic Triazine Polymer Derivatives as Antibacterial And Anti-atopic Agents in Mice Model.
Journal: Scientific reports
Published: July 03, 2019
Pyrrole-Based Macrocyclic Small-Molecule Inhibitors That Target Oocyte Maturation.
Journal: ChemMedChem
Published: January 24, 2017
Characterization of oleanolic acid derivative for colon cancer targeting with positron emission tomography.
Journal: Journal of drug targeting
Published: November 14, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026